Brief: XSpray Aims For Up-Listing H1 2020

Xspray Pharma publ AB

10/09/2019 14:02

Sept 10 (Reuters) - XSpray Pharma AB (publ)  XSPRAY.ST :
    * XSPRAY AIMS FOR UP-LISTING FIRST HALF OF 2020
    * REVISES SCHEDULE FOR PLANNED LIST CHANGE FROM NASDAQ FIRST
NORTH
GROWTH MARKET TO NASDAQ STOCKHOLM, WITH GOAL TO COMPLETE
UP-LISTING IN FIRST HALF OF 2020
    * DECISION MEANS CO CAN FOCUS ON SCALING UP MANUFACTURING
PROCESS
OF ITS LEADING PRODUCT CANDIDATE HYNAP-DASA, TAKING PRODUCT
THROUGH CLINICAL STUDIES, AND SUBMIT ANDA APPLICATION TO FDA
DURING SUMMER 2020

Source text for Eikon:  ID:nWkr1zrT8p 
Further company coverage:  XSPRAY.ST 

 (Gdynia Newsroom)
 ((gdynia.newsroom@thomsonreuters.com; +48 58 772 0920;))